Publication | Closed Access
A Phase I Study of<i>In vitro</i>Expanded Natural Killer T Cells in Patients with Advanced and Recurrent Non–Small Cell Lung Cancer
239
Citations
33
References
2006
Year
The clinical trial with activated Valpha24 NKT cell administration was well tolerated and carried out safely with minor adverse events even in patients with advanced diseases.
| Year | Citations | |
|---|---|---|
Page 1
Page 1